Analysts’ Recent Ratings Changes for Enhabit (EHAB)

A number of research firms have changed their ratings and price targets for Enhabit (NYSE: EHAB):

• 1/13/2026 – Enhabit was upgraded by analysts at Cowen Inc to a “buy” rating.
• 1/13/2026 – Enhabit was upgraded by analysts at Deutsche Bank Aktiengesellschaft to a “buy” rating.
• 1/13/2026 – Enhabit was upgraded by analysts at TD Cowen from a “hold” rating to a “buy” rating. They now have a $12.00 price target on the stock, up previously from $9.00.
• 1/8/2026 – Enhabit was upgraded by analysts at UBS Group AG from a “neutral” rating to a “buy” rating. They now have a $12.00 price target on the stock, up previously from $8.50.
• 1/8/2026 – Enhabit was given a new $12.00 price target on by analysts at Wolfe Research.
• 1/7/2026 – Enhabit was given a new $10.50 price target on by analysts at Truist Financial Corporation. They now have a “hold” rating on the stock.
• 12/29/2025 – Enhabit had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – Enhabit had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/16/2025 – Enhabit had its “buy” rating reaffirmed by analysts at Jefferies Financial Group Inc..
• 12/16/2025 – Enhabit had its “buy” rating reaffirmed by analysts at Citigroup Inc..
• 12/15/2025 – Enhabit had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/8/2025 – Enhabit had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/1/2025 – Enhabit had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 11/25/2025 – Enhabit had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 11/19/2025 – Enhabit had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.